吸入性皮质类固醇对健康的呼吸道的影响
Emanuele Marchi1, Timothy S C Hinks1, Matthew Richardson2
1NIHR Oxford Respiratory BRC and Respiratory Medicine Unit, Experimental Medicine, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK.
Allergy
|April 30, 2024
概括
在健康的呼吸道中吸入的皮质类固醇 (ICS) 降低了与先天性和适应性免疫相关的基因表达. 这表明,气道平衡包括对ICS敏感的2型信号传递.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 吸入性皮质类固醇 (ICS) 对健康的呼吸道的影响尚不清楚.
- 对健康个体的ICS影响的研究对于区分与疾病特异性变化至关重要.
研究的目的:
- 确定ICS对健康呼吸道基因表达的影响.
- 为了避免与疾病特异性基因表达和ICS响应性相关的混因素.
主要方法:
- 一项随机的,开放的支气管检查研究,涉及30名健康志愿者.
- 参与者接受了高剂量的流动 propionate (ICS) 或没有治疗4周.
- 分析包括免疫组织化学,大量RNA测序,DNA甲基化阵列,以及气道活检和刷牙上的元基因组学.
主要成果:
- 在ICS治疗中,乙氨基细胞,免疫病理学,中性细胞,FeNO,FEV1,微生物组或DNA甲基化发生的变化很小.
- 在呼吸道刷牙和活检中,ICS提高了特定基因的调节.
- ICS显著降低了与2型炎症相关的基因,T细胞和B细胞免疫力以及先天免疫力.
结论:
- 在健康的呼吸道中四周的ICS暴露抑制了与先天性和适应性免疫相关的基因表达.
- 这种抑制包括2型炎症的关键标志物.
- 健康的呼吸道平衡似乎涉及对ICS敏感的强力型-2信号传递.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
239
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
239
COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
Inhaled Medications
255
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
255
Drugs Used in Lower Respiratory Disorders: Overview
424
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
424
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Antiasthma Drugs: β2-Adrenoceptor Agonists
255
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
255


